We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $814M
1-Year Est. Return 40.24%
This Fund
S&P 500
This Quarter Est. Return
+10.59%
1 Year Est. Return
+40.24%
3 Year Est. Return
+82.87%
5 Year Est. Return
+77.64%
10 Year Est. Return
+275.61%
AUM
$703M
AUM Growth
+$97.6M
Cap. Flow
+$32.1M
Cap. Flow %
4.57%
Top 10 Hldgs %
21.41%
Holding
254
New
14
Increased
153
Reduced
17
Closed
8

Top Buys

Rank Stock Value
1
UCTT
Ultra Clean Holdings
UCTT
+$2.1M
2
BALY icon
Bally's
BALY
+$1.93M
3
MTRN icon
Materion
MTRN
+$1.8M
4
MSFT icon
Microsoft
MSFT
+$790K
5
CHX
ChampionX
CHX
+$586K

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$1.69M
2
BMY icon
Bristol-Myers Squibb
BMY
+$1.58M
3
PFPT
Proofpoint, Inc.
PFPT
+$1.36M
4
ZM icon
Zoom
ZM
+$582K
5
EA icon
Electronic Arts
EA
+$433K

Sector Composition

Rank Sector Weight
1 Technology 35.4%
2 Financials 10.56%
3 Healthcare 10.17%
4 Industrials 7.66%
5 Communication Services 6.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDSI
126
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.36M 0.19%
379,602
+30,137
+9% +$106K
MODN
127
DELISTED
MODEL N, INC.
MODN
$1.33M 0.19%
38,697
+3,060
+9% +$112K
CXDO icon
128
Crexendo
CXDO
$249M
$1.32M 0.19%
216,674
+19,345
+10% +$111K
EGAN icon
129
eGain
EGAN
$182M
$1.29M 0.18%
112,726
LUV icon
130
Southwest Airlines
LUV
$23.6B
$1.27M 0.18%
24,024
+5,738
+31% +$344K
GNSS icon
131
Genasys
GNSS
$78.8M
$1.25M 0.18%
227,603
+18,737
+9% +$114K
LHX icon
132
L3Harris
LHX
$52.3B
$1.24M 0.18%
5,743
+287
+5% +$61.7K
VER
133
DELISTED
VEREIT, Inc.
VER
$1.19M 0.17%
25,937
MRCY icon
134
Mercury Systems
MRCY
$5.69B
$1.14M 0.16%
17,237
+1,595
+10% +$110K
MNTV
135
DELISTED
Momentive Global Inc. Common Stock
MNTV
$1.13M 0.16%
53,484
+5,253
+11% +$102K
EGRX
136
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.03M 0.15%
24,000
JPM icon
137
JPMorgan Chase
JPM
$901B
$920K 0.13%
5,916
+1,228
+26% +$193K
TMO icon
138
Thermo Fisher Scientific
TMO
$196B
$804K 0.11%
1,593
+19
+1% +$8.96K
BAC icon
139
Bank of America
BAC
$424B
$787K 0.11%
19,095
DT icon
140
Dynatrace
DT
$13B
$708K 0.1%
12,111
+1
+0% +$52
WST icon
141
West Pharmaceutical
WST
$24.9B
$694K 0.1%
1,933
-15
-0.8% -$4.96K
LRCX icon
142
Lam Research
LRCX
$384B
$590K 0.08%
9,070
IJH icon
143
iShares Core S&P Mid-Cap ETF
IJH
$121B
$586K 0.08%
10,905
+240
+2% +$13K
TER icon
144
Teradyne
TER
$52.2B
$584K 0.08%
4,359
+87
+2% +$11.1K
GRMN
145
Garmin
GRMN
$47.2B
$575K 0.08%
3,974
GMAB icon
146
Genmab
GMAB
$17.1B
$573K 0.08%
14,045
+11
+0.1% +$424
CVS icon
147
CVS Health
CVS
$137B
$570K 0.08%
6,833
+500
+8% +$40.9K
DOCU
148
DocuSign
DOCU
$9.99B
$553K 0.08%
+1,979
New +$443K
CRWD icon
149
CrowdStrike
CRWD
$202B
$504K 0.07%
+8,028
New +$432K
ICE icon
150
Intercontinental Exchange
ICE
$80.1B
$484K 0.07%
4,074
+1
+0% +$115

Similar funds

Stanley-Laman Group's Q2 2021 Portfolio in Review

As of Q2 2021, Stanley-Laman Group held 254 positions worth $703M, up 16% from $606M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Stanley-Laman Group deployed $32.1M of net new capital in Q2 2021, opening 14 new positions and adding to 153 existing holdings. Its largest new stake was Ultra Clean Holdings: 39,182 shares worth $2.1M.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 35% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Zoom, an estimated $582K trimmed.

  • Stanley-Laman Group's largest Q2 2021 buy was Ultra Clean Holdings: 39,182 shares worth $2.1M.
  • Stanley-Laman Group added most to Microsoft in Q2 2021, an estimated $790K increase.
  • Stanley-Laman Group's biggest Q2 2021 reduction was Zoom, cutting an estimated $582K.
  • Stanley-Laman Group fully exited Amgen in Q2 2021, selling an estimated $1.69M.
  • Stanley-Laman Group's ten largest holdings make up 21% of its $703M portfolio in Q2 2021.
  • Stanley-Laman Group opened 14 new positions and closed 8 in Q2 2021.
  • Stanley-Laman Group's portfolio value rose 16% quarter-over-quarter to $703M.

Based on Stanley-Laman Group's 13F filing for Q2 2021, filed 28 Jul 2021.